These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14607952)

  • 41. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.
    Grillot D; Michel M; Müller I; Tougne C; Rènia L; Mazier D; Corradin G; Lambert PH; Louis JA; Del Guidice G
    Eur J Immunol; 1990 Jun; 20(6):1215-22. PubMed ID: 1695152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prenatal malaria immune experience affects acquisition of Plasmodium falciparum merozoite surface protein-1 invasion inhibitory antibodies during infancy.
    Dent A; Malhotra I; Mungai P; Muchiri E; Crabb BS; Kazura JW; King CL
    J Immunol; 2006 Nov; 177(10):7139-45. PubMed ID: 17082631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria.
    Calvo PA; Daly TM; Long CA
    Exp Parasitol; 1996 Jan; 82(1):54-64. PubMed ID: 8617331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae.
    Hui GS; Gosnell WL; Case SE; Hashiro C; Nikaido C; Hashimoto A; Kaslow DC
    J Immunol; 1994 Sep; 153(6):2544-53. PubMed ID: 8077664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
    Wang L; Goschnick MW; Coppel RL
    Infect Immun; 2004 Oct; 72(10):6172-5. PubMed ID: 15385527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.
    Hunter RL; Kidd MR; Olsen MR; Patterson PS; Lal AA
    J Immunol; 1995 Feb; 154(4):1762-9. PubMed ID: 7836760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting merozoite surface protein-1.
    Matsumoto S; Yukitake H; Kanbara H; Yamada T
    Vaccine; 1999 Dec; 18(9-10):832-4. PubMed ID: 10580196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel antimalarial antibodies highlight the importance of the antibody Fc region in mediating protection.
    Pleass RJ; Ogun SA; McGuinness DH; van de Winkel JG; Holder AA; Woof JM
    Blood; 2003 Dec; 102(13):4424-30. PubMed ID: 12855589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasmodium yoelii can ablate vaccine-induced long-term protection in mice.
    Wykes MN; Zhou YH; Liu XQ; Good MF
    J Immunol; 2005 Aug; 175(4):2510-6. PubMed ID: 16081823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A single injection of 19 kda carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 (PyMSP1(19)) formulated with Montanide ISA and CpG ODN induces protective immune response in mice.
    Hirunpetcharat C; Mahakunkijcharoen Y; Jeamwattanalert P; Kittigul L; Mahannop P; Pichyangkul S
    Asian Pac J Allergy Immunol; 2011 Sep; 29(3):252-9. PubMed ID: 22053595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
    Xu L; Pei X; Berzins K; Chaudhuri A
    Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice.
    Kamali AN; Marín-García P; Azcárate IG; Diez A; Puyet A; Bautista JM
    Immunobiology; 2012 Aug; 217(8):823-30. PubMed ID: 22658767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
    Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
    Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection.
    Leite JA; Bargieri DY; Carvalho BO; Albrecht L; Lopes SC; Kayano AC; Farias AS; Chia WN; Claser C; Malleret B; Russell B; Castiñeiras C; Santos LM; Brocchi M; Wunderlich G; Soares IS; Rodrigues MM; Rénia L; Costa FT
    Infect Immun; 2015 Oct; 83(10):3781-92. PubMed ID: 26169268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus.
    King CL; Malhotra I; Wamachi A; Kioko J; Mungai P; Wahab SA; Koech D; Zimmerman P; Ouma J; Kazura JW
    J Immunol; 2002 Jan; 168(1):356-64. PubMed ID: 11751981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase.
    Dutta S; Tewari A; Balaji C; Verma R; Moitra A; Yadav M; Agrawal P; Sahal D; Jarori GK
    Malar J; 2018 Aug; 17(1):304. PubMed ID: 30126436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes.
    Zhu F; Liu T; Zhao C; Lu X; Zhang J; Xu W
    J Immunol; 2017 Jan; 198(1):300-307. PubMed ID: 27903741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental asexual blood stage malaria immunity.
    Amante FH; Good MF
    Curr Protoc Immunol; 2001 May; Chapter 19():Unit 19.4. PubMed ID: 18432755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The oligomerization domain of C4-binding protein (C4bp) acts as an adjuvant, and the fusion protein comprised of the 19-kilodalton merozoite surface protein 1 fused with the murine C4bp domain protects mice against malaria.
    Ogun SA; Dumon-Seignovert L; Marchand JB; Holder AA; Hill F
    Infect Immun; 2008 Aug; 76(8):3817-23. PubMed ID: 18474650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite.
    Freeman RR; Trejdosiewicz AJ; Cross GA
    Nature; 1980 Mar; 284(5754):366-8. PubMed ID: 7360274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.